Characteristics | Overall Patients | low CRP | High CRP | P value | Low LHR | High LHR | P value |
---|---|---|---|---|---|---|---|
 | (n=5221) | (n=3565) | (n=1656) |  | (n=4634) | (n=587) |  |
Gender (%) | |||||||
 male | 3061 (58.6) | 1927 (54.1) | 1134 (68.5) | <0.001 | 2658 (57.4) | 403 (68.7) | <0.001 |
 female | 2160 (41.4) | 1638 (45.9) | 522 (31.5) |  | 1976 (42.6) | 184 (31.3) |  |
 Age (mean (SD)) | 59.41 (11.15) | 58.63 (11.17) | 61.10 (10.93) | <0.001 | 59.44 (11.07) | 59.21 (11.76) | 0.63 |
 Age, ≥65 years (%) | 1767 (33.8) | 1102 (30.9) | 665 (40.2) | <0.001 | 1571 (33.9) | 196 (33.4) | 0.841 |
 BMI (mean (SD)) | 22.57 (3.51) | 22.81 (3.52) | 22.07 (3.44) | 0.006 | 22.51 (3.47) | 23.09 (3.77) | <0.001 |
BMI, kg/m2 (%) | |||||||
 <18.5 | 616 (11.8) | 370 (10.4) | 246 (14.9) | 0.002 | 557 (12.0) | 59 (10.1) | 0.002 |
 18.5-23.9 | 2899 (55.5) | 1942 (54.5) | 957 (57.8) |  | 2604 (56.2) | 295 (50.3) |  |
 24-27.9 | 1162 (22.3) | 840 (23.6) | 322 (19.4) |  | 1005 (21.7) | 157 (26.7) |  |
 ≥28 | 544 (10.4) | 413 (11.6) | 131 (7.9) |  | 468 (10.1) | 76 (12.9) |  |
 Diabetes, yes (%) | 530 (10.2) | 321 (9.0) | 209 (12.6) | <0.001 | 461 (9.9) | 69 (11.8) | 0.196 |
 Hypertension, yes (%) | 1085 (20.8) | 685 (19.2) | 400 (24.2) | <0.001 | 935 (20.2) | 150 (25.6) | 0.003 |
 Coronary heart disease, yes (%) | 268 (5.1) | 180 (5.0) | 88 (5.3) | 0.737 | 237 (5.1) | 31 (5.3) | 0.942 |
 Smoking, yes (%) | 2431 (46.6) | 1501 (42.1) | 930 (56.2) | <0.001 | 2112 (45.6) | 319 (54.3) | <0.001 |
 Alcohol, yes (%) | 1167 (22.4) | 743 (20.8) | 424 (25.6) | <0.001 | 1018 (22.0) | 149 (25.4) | 0.069 |
Tumor types (%) | |||||||
 Lung cancer | 1776 (34.0) | 1103 (30.9) | 673 (40.6) | <0.001 | 1606 (34.7) | 170 (29.0) | <0.001 |
 Gastric cancer | 766 (14.7) | 561 (15.7) | 205 (12.4) |  | 689 (14.9) | 77 (13.1) |  |
 Esophageal cancer | 313 (6.0) | 194 (5.4) | 119 (7.2) |  | 273 (5.9) | 40 (6.8) |  |
 Colorectal cancer | 917 (17.6) | 679 (19.0) | 238 (14.4) |  | 785 (16.9) | 132 (22.5) |  |
 Other digestive cancers | 394 (7.5) | 238 (6.7) | 156 (9.4) |  | 342 (7.4) | 52 (8.9) |  |
 Breast cancer | 464 (8.9) | 412 (11.6) | 52 (3.1) |  | 437 (9.4) | 27 (4.6) |  |
 Female reproductive cancer | 177 (3.4) | 114 (3.2) | 63 (3.8) |  | 159 (3.4) | 18 (3.1) |  |
 Urological cancer | 132 (2.5) | 74 (2.1) | 58 (3.5) |  | 112 (2.4) | 20 (3.4) |  |
 Nasopharyngeal cancer | 126 (2.4) | 101 (2.8) | 25 (1.5) |  | 108 (2.3) | 18 (3.1) |  |
 Other cancer | 156 (3.0) | 89 (2.5) | 67 (4.0) |  | 123 (2.7) | 33 (5.6) |  |
Tumor stage (%) | |||||||
 I | 441 (8.4) | 367 (10.3) | 74 (4.5) | <0.001 | 416 (9.0) | 25 (4.3) | <0.001 |
 II | 943 (18.1) | 760 (21.3) | 183 (11.1) |  | 872 (18.8) | 71 (12.1) |  |
 III | 1413 (27.1) | 1042 (29.2) | 371 (22.4) |  | 1268 (27.4) | 145 (24.7) |  |
 IV | 2424 (46.4) | 1396 (39.2) | 1028 (62.1) |  | 2078 (44.8) | 346 (58.9) |  |
 Surgery, yes (%) | 2596 (49.7) | 1980 (55.5) | 616 (37.2) | <0.001 | 2351 (50.7) | 245 (41.7) | <0.001 |
 Radiotherapy, yes (%) | 581 (11.1) | 399 (11.2) | 182 (11.0) | 0.989 | 507 (10.9) | 74 (12.6) | 0.255 |
 Chemotherapy, yes (%) | 3312 (63.4) | 2281 (64.0) | 1031 (62.3) | 0.202 | 2977 (64.2) | 335 (57.1) | 0.001 |
 Total protein, g/L (mean (SD)) | 68.63 (6.75) | 69.01 (6.31) | 67.83 (7.55) | <0.001 | 68.58 (6.68) | 69.03 (7.28) | 0.126 |
 Albumin, g/L (mean (SD)) | 39.04 (5.01) | 40.32 (4.42) | 36.31 (5.09) | <0.001 | 39.22 (4.92) | 37.64 (5.48) | <0.001 |
 CRP, mg/L (median (IQR)) | 3.71 (13.20) | 3.10 (2.60) | 30.80 (46.18) | <0.001 | 3.44 (10.62) | 12.20 (42.46) | <0.001 |
 TC, mmol/L (mean (SD)) | 4.60 (1.11) | 4.68 (1.07) | 4.42 (1.19) | <0.001 | 4.50 (1.02) | 5.39 (1.44) | <0.001 |
 Blood glucose, mmol/L (mean (SD)) | 5.78 (1.76) | 5.69 (1.61) | 5.97 (2.04) | <0.001 | 5.73 (1.70) | 6.15 (2.14) | <0.001 |
 TG, mmol/L (mean (SD)) | 1.50 (1.49) | 1.53 (1.22) | 1.43 (1.94) | 0.018 | 1.45 (1.54) | 1.85 (0.99) | <0.001 |
 HDL-c, mmol/L (mean (SD)) | 1.22 (0.37) | 1.28 (0.33) | 1.11 (0.43) | <0.001 | 1.27 (0.37) | 0.89 (0.25) | <0.001 |
 LDL-c, mmol/L (mean (SD)) | 2.82 (0.88) | 2.82 (0.83) | 2.81 (0.99) | 0.617 | 2.69 (0.76) | 3.84 (1.13) | <0.001 |
 LHR (mean (SD)) | 2.49 (1.30) | 2.34 (0.98) | 2.81 (1.75) | <0.001 | 2.22 (0.65) | 4.67 (2.51) | <0.001 |
 TC/HDL-c (mean (SD)) | 4.01 (1.60) | 3.85 (1.26) | 4.35 (2.12) | <0.001 | 3.69 (0.87) | 6.55 (3.10) | <0.001 |
 TG/HDL-c (mean (SD)) | 1.38 (1.43) | 1.34 (1.27) | 1.47 (1.72) | 0.002 | 1.25 (1.24) | 2.41 (2.19) | <0.001 |
 TyG (mean (SD)) | 3.88 (0.29) | 3.89 (0.29) | 3.86 (0.29) | 0.012 | 7.03 (0.58) | 7.36 (0.58) | <0.001 |
 KPS (mean (SD)) | 85.40 (12.35) | 87.31 (10.37) | 81.27 (15.00) | <0.001 | 85.97 (11.87) | 80.87 (14.92) | <0.001 |
 KPS, <60 (%) | 307 (5.9) | 123 (3.5) | 184 (11.1) | <0.001 | 242 (5.2) | 65 (11.1) | <0.001 |
 Nutritional intervention, yes (%) | 1000 (19.2) | 610 (17.1) | 390 (23.6) | <0.001 | 865 (18.7) | 135 (23.0) | 0.014 |